Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan

Hepatitis B virus vaccination and antiviral therapies reduce the risk of hepatocellular carcinoma (HCC). However, the lifetime healthcare expenditure involved in caring for HCC patients remains unclear. We examined the use and direct costs of healthcare services for a cohort of HCC patients to the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguang, Seng-Howe, Wu, Cheng-Kun, Liang, Chih-Ming, Tai, Wei-Chen, Yang, Shih-Cheng, Ku, Ming-Kun, Yuan, Lan-Ting, Wang, Jiunn-Wei, Tseng, Kuo-Lun, Hung, Tsung-Hsing, Hsu, Pin-I, Wu, Deng-Chyang, Chuah, Seng-Kee, Hsu, Chien-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313960/
https://www.ncbi.nlm.nih.gov/pubmed/30486324
http://dx.doi.org/10.3390/ijerph15122655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313960/
https://www.ncbi.nlm.nih.gov/pubmed/30486324
http://dx.doi.org/10.3390/ijerph15122655

Ejemplares similares